SGK3 (CISK) may induce tumor angiogenesis (Hypothesis)

Hou,Minzhi; Lai,Yingrong; He,Shanyang; He,Weiling; Shen,Hongwei; Ke,Zunfu

doi:10.3892/ol.2015.3182

SGK3 (CISK) may induce tumor angiogenesis (Hypothesis)

Authors:
- Minzhi Hou
- Yingrong Lai
- Shanyang He
- Weiling He
- Hongwei Shen
- Zunfu Ke
View Affiliations

Affiliations: Department of Gynecology, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Pathology, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: May 6, 2015 https://doi.org/10.3892/ol.2015.3182
Pages: 23-26

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Serum- and glucocorticoid-inducible protein kinase 3 (SGK3), also known as cytokine-independent survival kinase (CISK), encoded by chromosome 8q12.2, is a downstream mediator of phosphatidylinositol 3‑kinase (PI3K) oncogenic signaling. As a downstream target of PI3K, SGK3 has been reported to mediate pivotal roles in oncogenic progress in various cancers, including breast cancer, ovarian cancer and hepatocellular carcinoma. Functionally parallel to v‑akt murine thymoma viral oncogene homolog (AKT)/protein kinase B, SGK3 serves as a hallmark mediating glycogen synthase kinase‑β (GSK3‑β), B‑cell lymphoma (Bcl)‑2‑associated death promoter, forkead family of transcription factors, Bcl‑extra large, Bcl‑2, mammalian target of rapamycin, C‑X‑C chemokine receptor type 4 (CXCR4) and numerous other molecules in cell proliferation, growth, survival, migration and even tumor angiogenesis. Tumor angiogenesis is recognized as an essential step for tumor growth, invasion and metastasis, and it has become an intriguing target for anticancer drug development for tumor investigators worldwide. An abundance of experiments have been performed to investigate the role of the phosphoinositide 3‑kinase (PI3K)/AKT pathway in regulating tumor angiogenesis. The mechanism of angiogenesis regulated by the PI3K/AKT pathway is, to a certain extent, clear. Although a number of SGK3 target molecules, including CXCR4 and GSK3β, have demonstrated potential roles in promoting angiogenesis, the exact association between angiogenesis and SGK3 remains unclear. Thus, we hypothesize that SGK3, parallel to AKT, may also be important in mediating angiogenesis. Identifying the role of SGK3 in tumor angiogenesis will certainly present a novel perspective on the malignant transformation of tumors, as well as a target for tumor therapy.

View Figures

View References

1	Xu J, Liu D, Gill G and Songyang Z: Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides. J Cell Biol. 154:699–705. 2001. View Article : Google Scholar : PubMed/NCBI
2	Xu J, Wan M, He Q, et al: SGK3 is associated with estrogen receptor expression in breast cancer. Breast Cancer Res Treat. 134:531–541. 2012. View Article : Google Scholar : PubMed/NCBI
3	Liu M, Chen L, Chan TH, et al: Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma. Hepatology. 55:1754–1765. 2012. View Article : Google Scholar : PubMed/NCBI
4	Liu D, Yang X and Songyang Z: Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol. 10:1233–1236. 2000. View Article : Google Scholar : PubMed/NCBI
5	Kobayashi T and Cohen P: Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J. 339:319–328. 1999. View Article : Google Scholar : PubMed/NCBI
6	Xu J, Liao L, Qin J, et al: Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK. J Biol Chem. 284:14377–14385. 2009. View Article : Google Scholar : PubMed/NCBI
7	Buse P, Tran SH, Luther E, et al: Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J Biol Chem. 274:7253–7263. 1999. View Article : Google Scholar : PubMed/NCBI
8	Caers J, van Valckenborgh E, Menu E, et al: Unraveling the biology of multiple myeloma disease: Cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment. Bull Cancer. 95:301–313. 2008.PubMed/NCBI
9	Bruhn MA, Pearson RB, Hannan RD and Sheppard KE: AKT-independent PI3-K signaling in cancer - emerging role for SGK3. Cancer Manag Res. 5:281–292. 2013.PubMed/NCBI
10	Ellson CD, Andrews S, Stephens LR and Hawkins PT: The PX domain: a new phosphoinositide-binding module. J Cell Sci. 115:1099–1105. 2002.PubMed/NCBI
11	Bruhn MA, Pearson RB, Hannan RD and Sheppard KE: Second AKTthe rise of SGK in cancer signalling. Growth Factors. 28:394–408. 2010. View Article : Google Scholar : PubMed/NCBI
12	Slagsvold T, Marchese A, Brech A and Stenmark H: CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. EMBO J. 25:3738–3749. 2006. View Article : Google Scholar : PubMed/NCBI
13	Gassmann P, Haier J, Schlüter K, et al: CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia. 11:651–661. 2009. View Article : Google Scholar : PubMed/NCBI
14	Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
15	Cai W and Chen X: Multimodality molecular imaging of tumor angiogenesis. J Nucl Med. 49(Suppl 2): 113S–128S. 2008.PubMed/NCBI
16	Ferrara N: VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
17	Okumura N, Yoshida H, Kitagishi Y, et al: PI3K/AKT/PTEN signaling as a molecular target in leukemia angiogenesis. Adv Hematol. 2012:8430852012.PubMed/NCBI
18	Su Y, Gao L, Teng L, et al: Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways. J Transl Med. 11:1322013. View Article : Google Scholar : PubMed/NCBI
19	You W, Gao H, Fan L, et al: Foxc2 regulates osteogenesis and angiogenesis of bone marrow mesenchymal stem cells. BMC Musculoskelet Disord. 14:1992013. View Article : Google Scholar : PubMed/NCBI
20	Zhou F, Xue M, Qin D, et al: HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway. PLoS One. 8:e531452013. View Article : Google Scholar : PubMed/NCBI
21	Pang L, Zhang Y, Yu Y and Zhang S: Resistin promotes the expression of vascular endothelial growth factor in ovary carcinoma cells. Int J Mol Sci. 14:9751–9766. 2013. View Article : Google Scholar : PubMed/NCBI
22	Koshiba T, Hosotani R, Miyamoto Y, et al: Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res. 6:3530–3535. 2000.PubMed/NCBI
23	Darash-Yahana M, Pikarsky E, Abramovitch R, et al: Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18:1240–1242. 2004.PubMed/NCBI
24	Wang J, Wang J, Sun Y, et al: Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal. 17:1578–1592. 2005. View Article : Google Scholar : PubMed/NCBI
25	Dandamudi UB, Ghebremichael M, Sosman JA, et al: A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study. J Immunother. 36:490–495. 2013. View Article : Google Scholar : PubMed/NCBI